Caspofungin Acetate For Injection - Liquid Formulation, Dosage As Suggested | Recommended For Doctors, Store In Cold & Dry Place, Suitable For All

5000 INR (Approx.)

1583.0 INR (Approx.)

Injection

Injection

Other, Prescription (Rx)

Doctor

Doctor

Adults and Pediatric Patients (3 months and older) with invasive fungal infections

As Suggested

As per Instructions

Administer by intravenous infusion over approximately 1 hour, as directed by healthcare provider

cold & dry place

Cool & Dry Place

Store below 25AdegC, protect from light, do not freeze

30 Days

7 Days

Brand: CANSHIELD 50 MG VialActive Ingredient / Content: Caspofungin Acetate for Injection 50 mgCompany / Manufacturer: BDR Pharmaceuticals International Pvt. Ltd.Product DescriptionCANSHIELD 50 MG Vial is a sterile antifungal injectable formulation containing Caspofungin Acetate at a strength of 50 mg per vial. It belongs to the echinocandin class of antifungal agents and is designed for parenteral administration (IV infusion) only. Caspofungin acts by inhibiting the synthesis of (1,3) D glucan, an essential component of the fungal cell wall, helping to treat serious and invasive fungal infections caused by susceptible organisms such as Candida and Aspergillus species.This product is typically supplied as a lyophilized powder which must be reconstituted with sterile water for injection before intravenous use. It is intended for use under the supervision of a qualified healthcare professional in hospital or clinical settings.Key Features Composition: Caspofungin Acetate 50 mg per vial (antifungal agent) Therapeutic Category: Antifungal Echinocandin class Form: Sterile injectable (IV infusion) powder for reconstitution Route of Administration: Intravenous infusion by healthcare professional Prescription Status: Prescription medicine to be used under medical supervision Storage: Store in a cool, dry place; follow specific storage conditions indicated by the manufacturer (often refrigerated)Typical UsesThis antifungal injection is used to treat serious fungal infections, especially: Invasive candidiasis Esophageal candidiasis Invasive aspergillosis in patients refractory to or intolerant of other therapiesUse and dosing are determined by a clinician based on infection severity and patient factors.Important Notes Medical supervision required: The injection should be administered in a clinical setting by trained personnel. Monitor liver function: Regular liver function tests may be recommended during therapy.Potential side effects: May include fever, chills, rash, nausea, diarrhea, and increased liver enzymes.

Caspofungin Acetate